BYAM REBECCA (Chief Financial Officer) purchased 33.1% of their position (14.23K shares) of HCW BIOLOGICS INC. on the open market
Open‑market purchase worth $20.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/27/2026ACC: 0001493152-26-025474
Officer· Chief Financial Officer
Since Jul 2021
+28.47K
Net shares
Net buyer
$20.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
28.47K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+14.23K
Price / share
$1.41
Trade value
$20K
% of position
33.1%
5/22/2026
43.01K→57.24K
Total
Net shares
+14.23K
Net value
$20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/22/2026 | P · Purchase | +14.23K | $1.41 | $20K | 33.1% | 43.01K | 57.24K |
| Total | +14.23K | $20K | ||||||
Derivative Transactions1
Common Stock Purchase Warrant
Direct
Converts to
Common Stock
14.23K shares
Shares
+14.23K
Strike price
1.28
Held after
18.47K
Exercisable
—
5/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Stock Purchase Warrant Direct | Common Stock14.23K shares | 5/22/2026 | P · Purchase | +14.23K | 1.28 | — | 18.47K |